Global Markets for Nanoparticle Size Analysis Instrumentation in the Life Sciences
The global market for nanoparticle analysis equipment was valued at nearly $5.2 billion in 2011 and is expected to reach $5.3 billion in 2012. Total market value is expected to reach $6.8 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 5.1%.
- An overview of the global market for particle size analysis instrumentation used in the life sciences, including salient production technologies, geographies, and factors influencing demand
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Examination of how the development of nanoparticles and their rapid incorporation into the research and development, formulation, and production of drug products has led to the need for rapid and accurate analytical instrumentation for determining the size and characteristics of various particle materials in the nanometer size range
- Discussion of how growth in the industry is due to the availability of microchips, smaller circuit boards, and a variety of other advances in the overall electronic and digital imaging areas that have occurred in the last decade
- A breakdown of particle analysis products, including size analysis, shape analysis, molecular weight analysis, flow analysis, solubility analysis, zeta potential analysis, and molecular structure analysis
- Comprehensive company profiles of major players in the industry
- Patent analyses.
Current and projected product forecasts during the forecast period (2012 to 2017) are discussed. New product launches will be discussed. Revenue figures for 2011 are actual figures, except where actual results have not been reported, due to the timing of the release of this report.
The report includes analysis of leading and emerging nanoparticle instrumentation categories. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.
Market figures are based on revenues at the manufacturers’ level and are projected at 2011-dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, for new product introductions, expanded markets for existing products and other factors affecting the market.
Included in this report are forecasts by product, product category and by company from 2010 through 2017. The study is arranged to offer an overview of existing nanoparticle instrumentation technology, company, geography and mechanism of analysis with forecasts broken down and covered by geographic region or country.
Patent information is reviewed for various technologies. The status of approvals by regulatory agencies, where appropriate, is reviewed.
Figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.
All market share data presented is on a global basis, unless specifically noted.
Jackson Highsmith is a life sciences research consultant with more than 16 years of research experience. Jackson has been consulting with specialty pharmaceuticals and large pharmaceutical industry players since 2007. Prior to that, he worked at a large research consultancy, where he focused on in-depth research; he also has worked at a large pharmaceutical company in a wide range of medical therapeutics in early- and mid-stage drug development. Jackson Highsmith is a pseudonym of the author.